Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Pablo Tebas, M.D.

Pablo Tebas, M.D.

faculty photo
Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Academic Address: 502 Johnson Pavilion. Infectious Disease office.
Clinical Office: Hospital of the University of Pennsylvania. 3400 Spruce Street. Silverstein Pavilion 3rd floor. Suite D.
Philadelphia, Pa 19104
Office: 215-349-8091
Fax: 215-349-8011
Education:
MD
Universidad Autónoma de Madrid, Spain, 1985.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Selected Publications

Grant PM, Kitch D, McComsey GA, Dube MP, Haubrich R, Huang J, Riddler S, Tebas P, Zolopa AR, Collier AC, Brown TT: Low Baseline CD4+ Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy Initiation. Clinical infectious diseases 57(10): 1483-8, Nov 2013.

Wohl DA, Arnoczy G, Fichtenbaum CJ, Campbell T, Taiwo B, Hicks C, McComsey GA, Koletar S, Sax P, Tebas P, Ha B, Massengale K, Walsh K, Stein JH: Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study. Antiviral therapy Aug 2013.

Azzoni L, Foulkes AS, Papasavvas E, Mexas AM, Lynn KM, Mounzer K, Tebas, P, Jacobson JM, Frank I, O'Doherty U, Kostman J, Montaner LJ: Improved treatment for primary HIV infection by interferon-alfa therapy? Does HCV treatment in HIV/HCV coinfected patients help us to test this hypothesis? Reply to zur Wiesch and van Lunzen. J Infect Dis 208(2): 363, July 2013.

Kim RJ, Vaghani S, Zifchak LM, Quinn JH, He W, Tebas P, Frank I: In Vitro and In Vivo Effects of IGF-I on Adiposity in HIV-associated Metabolic Disease: A Pilot Study. Arch Med Res 44(5): 361-9, July 2013.

Diehl MC, Lee JC, Daniels SE, Tebas P, Khan AS, Giffear M, Sardesai NY, Bagarazzi ML: Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers. Human vaccines & immunotherapeutics 9(10), Jun 2013.

Maalouf N, Zhang S, Drechsler H, Brown G, Tebas P, Bedimo R: Hepatitis C co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients. J Bone Miner Res May 2013.

Azzoni L, Foulkes AS, Papasavvas E, Mexas AM, Lynn KM, Mounzer K, Tebas P, Jacobson JM, Frank I, O'Doherty U, Kostman J, Montaner LJ: Reply to zur Wiesch and van Lunzen. J Infect Dis May 2013.

Bedimo R, Tebas P: Bone: Increased fracture risk with HIV infection-a growing concern. Nat Rev Endocrinol 9(5): 260-1, May 2013.

Overton ET, Kitch D, Benson CA, Hunt PW, Stein JH, Smurzynski M, Ribaudo HJ, Tebas P: Effect of Statin Therapy in Reducing the Risk of Serious Non-AIDS-Defining Events and Nonaccidental Death. Clin Infect Dis 56(10): 1471-9, May 2013.

Bisson, G. P., Molefi, M., Bellamy, S., Thakur, R., Steenhoff, A., Tamuhla, N., Rantleru, T., Tsimako, I., Gluckman, S., Ravimohan, S., Weissman, D., Tebas, P.: Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clin Infect Dis 56(8): 1165-73, April 2013.

back to top
Last updated: 03/25/2014
The Trustees of the University of Pennsylvania